[1] SULIGA E, CIESLA E, GLUSZEK-OSUCH M, et al. Breastfeeding and prevalence of metabolic syndrome among perimenopausal women[J].Nutrients,2020, 12(9):2691-2699.
[2] 李晓文, 张伟涛, 许金平, 等. 仙灵骨葆胶囊联合雌激素替代疗法治疗围绝经期综合征患者的临床疗效[J].医学临床研究, 2020, 37(8):1216-1219.
[3] ILESANMI-OYELERE BL, BROUGH L, COAD J, et al. The relationship between nutrient patterns and bone mineral density in postmenopausal women [J].Nutrients,2019, 11(6):1262-1268.
[4] FAN H, CHEN S, GAO B, et al. Risk analysis of systemic levels of estrogen and adipokines as well as estrogen receptors from PBMCs in childbearing and perimenopausal women with obesity [J].Diabetes Metab Syndr Obes,2019, 12(3):1287-1295.
[5] 高妍. 妇科内分泌疾病诊疗手册[M]. 乌鲁木齐:新疆科学技术出版社, 2014:116-119.
[6] 杜顺珍. 临床常见妇科疾病诊治对策[M]. 长春:吉林科学技术出版社, 2013: 102-105.
[7] 赵霞. 现代临床常见妇科疾病诊治学[M]. 长春:吉林科学技术出版社, 2012:84-87.
[8] 张倩, 杜淑玲. 坤泰胶囊与替勃龙治疗围绝经期综合征的疗效及安全性比较[J].中国医药科学, 2020, 10(6):26-28.
[9] 中华医学会妇产科学分会绝经学组. 绝经期管理与激素补充治疗临床应用指南(2012版)[J].中华妇产科杂志, 2013, 48(10):795-799.
[10] TRENTI A, TEDESCO S, BOSCARO C, et al. Estrogen, angiogenesis, immunity and cell metabolism: solving the puzzle[J].Int J Mol Sci,2018, 19(3):859-865.
[11] 李祥芬, 高文芳, 李相宜, 等. 低剂量激素替代治疗糖尿病围绝经期综合征的疗效观察[J].西南国防医药, 2018, 28(2):135-137.
[12] ROSSI L M M, COPES R M, DAL OSTO L C, et al. Factors related with osteoporosis treatment in postmenopausal women [J].Medicine (Baltimore),2018, 97(28):115-124.
[13] 陈维媛, 赵春阳, 蔡佳怡, 等. 雌激素治疗绝经后骨质疏松的Meta分析[J].药物评价研究, 2019, 42(12):156-163.
[14] 左宏玲, 邓燕, 王艳芳, 等. 低剂量与标准剂量结合雌激素联合不同孕激素应用对围绝经期综合征患者骨密度的影响[J].中华妇产科杂志, 2018, 53(4):243-247.
2021, Vol. 38 
